CEFIXIME powder, for suspension

Nazione: Stati Uniti

Lingua: inglese

Fonte: NLM (National Library of Medicine)

Principio attivo:

CEFIXIME (UNII: 97I1C92E55) (CEFIXIME ANHYDROUS - UNII:XZ7BG04GJX)

Commercializzato da:

Dr. Reddy’s Laboratories, Inc

INN (Nome Internazionale):

CEFIXIME

Composizione:

CEFIXIME ANHYDROUS 100 mg in 5 mL

Via di somministrazione:

ORAL

Tipo di ricetta:

PRESCRIPTION DRUG

Indicazioni terapeutiche:

To reduce the development of drug resistant bacteria and maintain the effectiveness of Cefixime for oral suspension and other antibacterial drugs, Cefixime for oral suspension should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. In the absence of such data,local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Cefixime for oral suspension is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months of age or older with the following infections when caused by susceptible isolates of the designated bacteria: Uncomplicated Urinary Tract Infections caused by Escherichia coli and Proteus mirabilis Otitis media caused by Haemophilus influenzae , Moraxella ca

Dettagli prodotto:

Cefixime for oral suspension, USP is available for oral administration in following dosage forms, strengths and packages listed in the table below: After reconstitution: Store at room temperature or under refrigeration. Keep tightly closed.

Stato dell'autorizzazione:

Abbreviated New Drug Application

Scheda tecnica

CEFIXIME- CEFIXIME POWDER, FOR SUSPENSION
DR. REDDY’S LABORATORIES, INC
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
CEFIXIME FOR ORAL
SUSPENSION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION
FOR CEFIXIME FOR ORAL
SUSPENSION.
CEFIXIME FOR ORAL SUSPENSION USP, 100 MG/5 ML
CEFIXIME FOR ORAL SUSPENSION USP, 200 MG/5 ML
FOR ORAL ADMINISTRATION
INITIAL U.S. APPROVAL:1986
TO REDUCE THE DEVELOPMENT OF DRUG-RESISTANT BACTERIA AND MAINTAIN THE
EFFECTIVENESS OF
CEFIXIME FOR ORAL SUSPENSION, USP AND OTHER ANTIBACTERIAL DRUGS,
CEFIXIME FOR ORAL
SUSPENSION, USP SHOULD BE USED ONLY TO TREAT INFECTIONS THAT ARE
PROVEN OR STRONGLY
SUSPECTED TO BE CAUSED BY BACTERIA.
INDICATIONS AND USAGE
Cefixime for oral suspension, USP is a cephalosporin antibacterial
drug indicated for
• Uncomplicated Urinary Tract Infections ( 1.1)
• Otitis Media ( 1.2)
• Pharyngitis and Tonsillitis ( 1.3)
• Acute Exacerbations of Chronic Bronchitis ( 1.4)
• Uncomplicated Gonorrhea (cervical/urethral)( 1.5)
DOSAGE AND ADMINISTRATION
• Adults: 400 mg daily ( 2.1)
• Children: 8 mg/kg/day ( 2.2)
DOSAGE FORMS AND STRENGTHS
Oral Suspension: 100 mg/5 mL, 200 mg/5 mL ( 3)
CONTRAINDICATIONS
Contraindicated in patients with known allergy to cefixime or other
cephalosporins. ( 4)
WARNINGS AND PRECAUTIONS
• Hypersensitivity reactions including shock and fatalities have
been reported with cefixime. Discontinue
use if a reaction occurs. ( 5.1)
• _Clostridium difficile_ associated diarrhea: Evaluate if diarrhea
occurs. ( 5.2)
ADVERSE REACTIONS
Most common adverse reactions are gastrointestinal such as diarrhea
(16%), nausea (7%), loose stools
(6%), abdominal pain (3%), dyspepsia (3%), and vomiting. ( 6)
TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT DR.REDDY'S
LABORATORIES, INC. AT 1-888-
375-3784 OR FDA AT 1-800-FDA-1088 OR _WWW.FDA.GOV/MEDWATCH_.
DRUG INTERACTIONS
Elevated carbamazepine levels have been reported in postmarketing
experience when cefixime is
administered c